• Business Update: Motif Bio

News & Views

Business Update: Motif Bio

Jan 05 2021

Reclassified as an AIM Rule 15 cash shell, following completion of restructuring approved by shareholders in November 2019, Motif Bio plc (AIM: MTFB), announces a business update regarding progress towards completing a reverse take-over pursuant to AIM Rule 14 (“RTO”).

The Company is currently advancing the necessary work streams to complete the RTO process with a UK based candidate in the healthcare sector.  The Board expects to provide shareholders with a further update during the second half of January.

Following its reclassification as an AIM Rule 15 cash shell in January 2020, the Company is required to make an acquisition which constitutes a RTO by 28 January 2021, failing which the Company's admission to trading on AIM may be cancelled. At this stage, there can be no assurance that the Company will be able to complete this or any other RTO transaction.

The person responsible for the release of this announcement on behalf of Motif Bio is Jonathan Gold, President and Chief Business Officer.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.


Digital Edition

International Labmate July 2021

July 2021

In This Edition Articles - Deep characterisation and quantitative analysis - Seamless HPLC Method Transfer - How does a sample’s adventure unfold at Diamond? Mass Spectrometry & Spectr...

View all digital editions

Events

InformEx Zone at CPhl North America

Aug 10 2021 Pennsylvania, PA, USA & Online

Miconex

Aug 18 2021 Beijing, China

DioXin 2021

Aug 22 2021 Xi'an, China

ACS National Meeting & Expo, Fall 2021

Aug 22 2021 Atlanta, GA, USA & Virtual

Microscopy Conference 2021

Aug 22 2021 Digital event

View all events